Navigation Links
Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show
Date:11/9/2009

NBC’s Today Show featured a return of the Berns Triplets and their physician, Dr. Jill Waibel on Friday Nov. 6th 2009, The segment followed up with Chandra, Jordan and Trae Berns after their first appearance on the Today Show on May 28th 2009 in which they were interviewed by Matt Lauer regarding their treatments by Dr. Jill Waibel of Miami, FL with Lumenis’ UltraPulse TotalFX laser.

(PRWEB) November 9, 2009 -- NBC’s Today Show featured a return of the Berns Triplets and their physician, Dr. Jill Waibel on Friday Nov. 6th 2009, The segment followed up with Chandra, Jordan and Trae Berns after their first appearance on the Today Show on May 28th 2009 in which they were interviewed by Matt Lauer regarding their treatments by Dr. Jill Waibel of Miami, FL with Lumenis’ UltraPulse TotalFX laser.    

The return segment, which aired Friday, November 6th, clearly showed viewers the dramatic improvement in the burn scars of all three sisters – scars which were inflicted upon them in an arson fire as infants. After twenty years of seeking treatment, they have found hope with Dr. Jill Waibel and Lumenis’ UltraPulse TotalFX system. Their remarkable results have inspired many other people with burn scars around the world to seek out Dr. Waibel and the TotalFX treatment to help them with their own scars.

“Chandra, Jordan and Trae have all shown considerable improvement in their scars after treatments using Lumenis’ TotalFX”, commented Dr. Waibel. “Because of their amazing progress, word has spread and I’ve treated over a hundred other burn patients in my practice alone. We are quickly advancing our knowledge on the science behind burn scars and the best solution for treatment”. Dr. Waibel is now a frequent guest lecturer on burn scar treatments at many physician societies and has quickly established
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME)
2. Lumenis Continued Dedication to Life-Saving Procedures Helps a Small Girl in Iceland Get a New Lease on Life
3. Lumenis, Worlds Largest Medical Laser Company, Honored by Premier Healthcare Alliance for Exceeding Performance Expectations
4. Lumenis UltraPulse TotalFX Treatment Featured on ABCNews 20/20 as a Secret Weapon for Treating for Burn Scars
5. Lumenis High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating Pain and Nuisance of Hair Removal for Men
6. Lumenis Completes $15 Million Equity Financing From New and Existing Investors
7. Lumenis High Speed LightSheer(R) Duet(TM) Featured on ABCs Good Morning America Health as the New Gold Standard for Laser Hair Removal
8. Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology
9. Exciting Innovation in Burn Scar Treatment Using Lumenis(R) UltraPulse(R) Laser Treatments Revealed on the Today Show
10. Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
11. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sentine...anceImaging(MRI)coilsandsoftwareandCalgaryScientif...ies,haveintroducedawebversionofAegis(TM)Breast4DAd...nterfaceisthefirsttrulyzero-footprintWebclientbase...ic,sPureWeb(TM)platformallowsforzero-footprintacce...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswir...,sCenterforDrugEvaluationandResearch,titled"ADiffi...ppearsintheNov.26,2009issueofTheNewEnglandJournalo...-bin/prnh/20090824/FDALOGO ) ,, Inthearticle,Wo...cesstopainmedicationforthosewhoneeditandmanagingth...
(Date:11/25/2009)...,, BroadPoliticalEndorsements,Business,andPres...RNewswire-USNewswire/--Onceagain,theNationalBipola...amationendorsingtheir"Safe,tilStable"program,which...sureforbipolardisorder.Today,theNationalBipolarFou...lExpressPriorityMailfromtheLt.GovernorofLouisianaM...
(Date:11/25/2009)... A fortuitous discovery that grew out of a collab...d potentially offer hope to the nearly 10 million ...ase. , Also known as hardening of the arteri...on circulatory problem in which narrowed arteries ...onsidered a red flag for vascular disease, heart a...
(Date:11/25/2009)...tuximab, already used to fight rheumatoid arthriti...ds , , WEDNESDAY, Nov. 25 (HealthDay New...lymphoma and rheumatoid arthritis now also shows s...th type 1 diabetes. , The drug, rituximab (Ritu... own insulin, even though the disease had destroye...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...t it is all over between Kate Moss and Pete Dohert...ican model , it seems that the waifish beauty will...implant. The implant will be the fifth one... she understands that Doherty needs help and will ...
...ammed Haneef, the man from Bangalore in southern I...avy price for a small act of indiscretion, it look...his cousins, the key players in the failed Glasgow...ly to crash. First Australian authorities alm...
...that more than 90 per cent of women undergoing fer...f fertility drugs meant to stimulate their ovaries...ans that the drugs may not work properly, but also...however increased during IVF, by giving them drugs...
...ol of Public Health (HSPH) shows that patients who...ic quality measures have a lower chance of dying ... The researchers calculate that if the lowest p... surveyed hospitals from acute myocardial infarcti...
...ess' has been named the most vegan-friendly food c...d by the animal rights group for its cheese-free p...is one of the 20 organisations recognised by PETA ...London with a pizza oven and chef imported from It...
...started walking on two legs is something yet to be...sized that bipedalism evolved as a way of reducin... study to fully examine this theory among humans a...ll trials to analyze walking energetics and biomec...
Other Medicine News:Health News:Haneefs Visa Revoked by Australia 2Health News:Lower Mortality Rates in Hospitals With Good Quality Care 2
(Date:11/25/2009)...Nov.25/PRNewswire/--CempraPharmaceuticalsInc.today...fexecutiveofficer,willpresentatthePiperJaffray21st...2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Ferna...ntibioticclinicalprogramsforthetreatmentofdrug-res...armaceuticals ,, Foundedin2006,CempraPharmaceu...
(Date:11/25/2009)...if.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announ...sPROTECT-1(theProspectiveRandomizedOralTherapyEval...82-B)inpatientswithmoderate-to-severeCrohn,sdiseas...ndtolerabilityprofile.Thestudydemonstratedevidence...sdefinedasa70-pointdecreaseintheCrohn,sDiseaseActi...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 1Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 2Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 4Ultimat Vodka Joins Fight Against Hunger 61545 1Ultimat Vodka Joins Fight Against Hunger 61545 2Shopko Announces Launch of e Commerce Platform 61542 1Shopko Announces Launch of e Commerce Platform 61542 2
...HAYWARD, Calif., Aug. 6 Kosan Biosciences,Incorpo... Inc. has initiated,a Phase 1 clinical trial of mo...187, a selective and potent motilin receptor agoni...hageal reflux disease (GERD) and potentially,other...ical trial is,designed to test the safety, tolerab...
...SAN DIEGO, Aug. 7 Vical Incorporated (Nasdaq:,VIC...r ended June 30, 2007.,Revenues for the second qua...nues of $7.3 million for the second quarter of 200... $8.2 million, or $0.21 per share, compared,with a... the second quarter,of 2006. The increase in net l...
Other Medicine Technology:Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 2Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 3Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 2Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 3Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 5Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 6
Jeweler Type Bipolar Insulated Forceps
Robb Tonsil Knife
Canfield Tonsil Knife
Converse Button End Bistoury
Medicine Products: